你即將離開本站

並前往https://www.fiercebiotech.com/biotech/fda-rejects-orphazyme-s-rare-disease-drug-continuing-wild-ride-for-danish-meme-stock

FDA rejects Orphazyme's rare disease drug, continuing wild ...

FDA Building 2 Orphazyme's setback comes one month after arimoclomol failed a phase 3 clinical trial in amyotrophic lateral sclerosis.

確定！ 回上一頁

查詢 「ORPH FDA」的人也找了：

  1. ORPH FDA approval
    2.
  2. Orphazyme A/S news
    3.
  3. Orphazyme
    4.
  4. FDA IND database
    5.
  5. Orphan drug Act
    6.
  6. ORPH stock
    7.
  7. Orphan FDA
    8.
  8. Orphazyme as adr
    9.